320 related articles for article (PubMed ID: 11245273)
21. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model.
Babaei S; Stewart DJ
Cardiovasc Res; 2002 Jul; 55(1):190-200. PubMed ID: 12062722
[TBL] [Abstract][Full Text] [Related]
22. Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.
Chakraborty S; Ain R
J Biol Chem; 2017 Apr; 292(16):6600-6620. PubMed ID: 28235804
[TBL] [Abstract][Full Text] [Related]
23. Development of new drugs in angiogenesis.
Ziche M; Donnini S; Morbidelli L
Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
[TBL] [Abstract][Full Text] [Related]
24. Constitutively synthesized nitric oxide is a physiological negative regulator of mammalian angiogenesis mediated by basic fibroblast growth factor.
Norrby K
Int J Exp Pathol; 2000 Dec; 81(6):423-7. PubMed ID: 11298189
[TBL] [Abstract][Full Text] [Related]
25. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
Michel JB
Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.
Florio T; Morini M; Villa V; Arena S; Corsaro A; Thellung S; Culler MD; Pfeffer U; Noonan DM; Schettini G; Albini A
Endocrinology; 2003 Apr; 144(4):1574-84. PubMed ID: 12639942
[TBL] [Abstract][Full Text] [Related]
27. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
Kroll J; Waltenberger J
Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat.
Zhang R; Wang L; Zhang L; Chen J; Zhu Z; Zhang Z; Chopp M
Circ Res; 2003 Feb; 92(3):308-13. PubMed ID: 12595343
[TBL] [Abstract][Full Text] [Related]
29. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
Morbidelli L; Pyriochou A; Filippi S; Vasileiadis I; Roussos C; Zhou Z; Loutrari H; Waltenberger J; Stössel A; Giannis A; Ziche M; Papapetropoulos A
Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R824-32. PubMed ID: 20032260
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.
Cianchi F; Cortesini C; Fantappiè O; Messerini L; Sardi I; Lasagna N; Perna F; Fabbroni V; Di Felice A; Perigli G; Mazzanti R; Masini E
Clin Cancer Res; 2004 Apr; 10(8):2694-704. PubMed ID: 15102673
[TBL] [Abstract][Full Text] [Related]
31. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis.
Rikitake Y; Hirata K; Kawashima S; Ozaki M; Takahashi T; Ogawa W; Inoue N; Yokoyama M
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):108-14. PubMed ID: 11788469
[TBL] [Abstract][Full Text] [Related]
32. The role of endothelial nitric oxide in the Substance P induced vasodilation in bovine dental pulp.
Karabucak B; Walsch H; Jou YT; Simchon S; Kim S
J Endod; 2005 Oct; 31(10):733-6. PubMed ID: 16186752
[TBL] [Abstract][Full Text] [Related]
33. [Physiological and physiopathological aspects of nitric acid in mammalian tissues].
Molero-Leal M
Invest Clin; 1998 Jun; 39(2):125-54. PubMed ID: 9707923
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide.
Brouet A; DeWever J; Martinive P; Havaux X; Bouzin C; Sonveaux P; Feron O
FASEB J; 2005 Apr; 19(6):602-4. PubMed ID: 15623570
[TBL] [Abstract][Full Text] [Related]
35. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis.
Kawasaki K; Smith RS; Hsieh CM; Sun J; Chao J; Liao JK
Mol Cell Biol; 2003 Aug; 23(16):5726-37. PubMed ID: 12897144
[TBL] [Abstract][Full Text] [Related]
36. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium.
Vincent MA; Montagnani M; Quon MJ
Curr Diab Rep; 2003 Aug; 3(4):279-88. PubMed ID: 12866989
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
38. Relative significance of the nitric oxide (NO)/cGMP pathway and K+ channel activation in endothelium-dependent vasodilation in the femoral artery of developing piglets.
Støen R; Lossius K; Persson AA; Karlsson JO
Acta Physiol Scand; 2001 Jan; 171(1):29-35. PubMed ID: 11350260
[TBL] [Abstract][Full Text] [Related]
39. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
Oelze M; Mollnau H; Hoffmann N; Warnholtz A; Bodenschatz M; Smolenski A; Walter U; Skatchkov M; Meinertz T; Münzel T
Circ Res; 2000 Nov; 87(11):999-1005. PubMed ID: 11090544
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells.
Lee PC; Kibbe MR; Schuchert MJ; Stolz DB; Watkins SC; Griffith BP; Billiar TR; Shears LL
Microvasc Res; 2000 Nov; 60(3):269-80. PubMed ID: 11078643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
